Hyderabad, India – 7th September 2026, According to Mordor Intelligence, the Gene Synthesis Market size is estimated at USD 2.85 billion in 2026 and is projected to reach USD 6.09 billion by 2031, growing at a CAGR of 16.38% during the forecast period. North America holds the largest market share, while Asia Pacific is expected to register the fastest growth. The market is supported by increasing genomics and next-generation sequencing research, growing demand for synthetic genes from biopharmaceutical companies, government funding for genomics programs, and improvements in DNA synthesis cost and turnaround time.
The market is also benefiting from the increasing use of gene synthesis services by pharmaceutical and biotechnology companies seeking faster design and development cycles. Emerging enzymatic DNA synthesis platforms are further supporting demand by offering alternatives to conventional chemical synthesis and helping address requirements for longer and higher-fidelity sequences.
Report Overview: https://www.mordorintelligence.com/industry-reports/gene-synthesis-market?utm_source=abnewswire
Gene Synthesis Market Trends
Growing Demand From Biopharmaceutical Research
One of the key Gene Synthesis Market trends is the increasing use of synthetic genes in biopharmaceutical research and development. Pharmaceutical and biotechnology companies use custom DNA sequences across areas such as cell and gene therapy, vaccine development, antibody research, and other therapeutic programs.
The growing number of research programs requiring customized genetic constructs is creating demand for providers that can deliver accurate sequences with suitable turnaround times. As biopharmaceutical developers seek to shorten research cycles, outsourced gene synthesis is becoming an important part of laboratory and development workflows.
Increasing Use in Gene and Cell Therapy Development
Gene and cell therapy development represents an important application area within the Gene Synthesis industry. These therapies require carefully designed genetic sequences for research, development, and manufacturing activities.
The growing pipeline of genetic medicines is creating demand for synthetic genes that can support therapeutic research and development. Providers with capabilities for complex sequences, high-fidelity synthesis, and related design services are positioned to serve the requirements of companies developing advanced therapies.
Emergence of Enzymatic DNA Synthesis
Another important trend influencing the Gene Synthesis Market is the growing interest in enzymatic DNA synthesis. Traditional chemical synthesis continues to have a strong position, particularly for shorter sequences, while enzymatic approaches are gaining attention for their potential to improve synthesis speed, sequence length, and production processes.
Enzymatic platforms can also reduce dependence on hazardous chemical solvents and support faster access to synthesized DNA. The development of these platforms is creating additional options for research laboratories and biotechnology companies seeking rapid DNA production.
Gene Synthesis Market Segmentation
The Gene Synthesis Market is segmented by synthesis method, service type, application, end user, and geography.
By Synthesis Method
Chemical Oligonucleotide Synthesis
Solid-Phase Phosphoramidite
Microchip-based Oligonucleotide Synthesis
Gene Assembly
PCR-mediated
Ligation-mediated
By Service Type
Antibody DNA Synthesis
Viral Gene Synthesis
Others
By Application
Gene and Cell Therapy Developments
Vaccine Development
Disease Diagnosis
By End User
Biopharmaceutical Companies
Academic & Government Institutes
CROs and CDMOs
By Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
South Korea
Australia
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
The Gene Synthesis Market share varies across regions according to biopharmaceutical activity, genomics research, government funding, biotechnology infrastructure, and demand for synthetic DNA. North America remains the largest regional market, supported by established biopharmaceutical and research capabilities, while Asia Pacific is expected to record the fastest growth as biotechnology investment and genomics activity increase.
Gene Synthesis Market Competitive Landscape
The competitive landscape of the Gene Synthesis industry includes global life science companies, specialized gene synthesis providers, biotechnology companies, and organizations developing new DNA synthesis platforms. Competition is influenced by sequence accuracy, turnaround time, synthesis capacity, service breadth, and the ability to support complex genetic constructs.
Key Players
Merck KGaA
Eurofins Genomics
Thermo Fisher Scientific
GenScript Biotech
Azenta Life Sciences
ATUM
Bio Basic
Beijing SBS Genetech
OriGene Technologies
Integrated DNA Technologies
Twist Bioscience
DNA Script
Ansa Biotechnologies
Evonetix
Telesis Bio
Synbio Technologies
Bioneer
ProteoGenix
Bio-Synthesis
ATLATL Innovations
The market remains moderately concentrated, with leading providers competing through broad gene synthesis portfolios, high-throughput capabilities, sequence quality, and supporting services. Specialized companies are also developing enzymatic and other synthesis approaches that address demand for longer sequences, faster production, and improved synthesis performance.
Conclusion
The Gene Synthesis Market forecast reflects continued demand for custom DNA as pharmaceutical companies, biotechnology firms, research institutions, and specialized service providers expand their use of synthetic biology and genomics. Increasing biopharmaceutical research, gene and cell therapy development, vaccine research, and disease diagnosis applications are expected to support continued market expansion.
Industry Related Reports
The Genetic Analysis Market is expected to grow from USD 12.20 billion in 2026 to USD 20.30 billion by 2031, registering a CAGR of 10.69%, driven by declining sequencing costs, expanding clinical reimbursement, national genomics programs, and growing adoption of AI-enabled variant interpretation.
https://www.mordorintelligence.com/industry-reports/genetic-analysis-market
The Gene Amplification Technologies Market reached USD 29.67 billion in 2025 and is projected to reach USD 34.79 billion by 2030, at a 3.24% CAGR, supported by increasing demand for molecular diagnostics, advancements in PCR-based technologies, and expanding applications across clinical and research settings.
https://www.mordorintelligence.com/industry-reports/gene-amplification-technologies-market
The DNA Polymerase Market is expected to grow from USD 331.13 million in 2025 to USD 417.91 million by 2030, at a 4.77% CAGR, driven by rising demand for DNA amplification and sequencing workflows, growth in molecular biology research, and expanding applications in biotechnology and diagnostics.
https://www.mordorintelligence.com/industry-reports/dna-polymerase-market
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
For any inquiries or to access the full report, please contact:
[email protected]
https://www.mordorintelligence.com/
Media ContactCompany Name: Mordor Intelligence Private LimitedContact Person: Jignesh ThakkarEmail: Send EmailPhone: +1 617-765-2493Address:11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli City: HyderabadState: Telangana 500008Country: IndiaWebsite: https://www.mordorintelligence.com/
